190 related articles for article (PubMed ID: 34760800)
1. Clinicopathological Correlation of Cyclooxygenase 2 Expression in Oral Submucous Fibrosis: An Immunohistochemical Study.
Divyambika CV; Sathasivasubramanian S; Vidyarani S; RaviDavid A; Harinee S; Vijayalakshmi R
J Int Soc Prev Community Dent; 2021; 11(5):553-560. PubMed ID: 34760800
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Significance of Cancer Stem Cell Markers (OCT-3/4 and SOX-2) in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma.
Venugopal DC; Caleb CL; Kirupakaran NP; Shyamsundar V; Ravindran S; Yasasve M; Krishnamurthy A; Harikrishnan T; Sankarapandian S; Ramshankar V
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189658
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 (COX-2) Expression in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Aparnadevi P; Nirmal RM; Veeravarmal V; Nandini DB; Kalyani C; Singh DN; Yoithapprabhunath TR
J Pharm Bioallied Sci; 2022 Jul; 14(Suppl 1):S769-S773. PubMed ID: 36110596
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of 8-hydroxydeoxyguanosine: A biomarker of oxidative DNA damage in oral submucous fibrosis.
Kulasekaran C; Devi M; Dhivya K; Vijayalakshmi D; Sathishkumar M; Madhanmohan A
J Oral Maxillofac Pathol; 2020; 24(3):536-541. PubMed ID: 33967493
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
[TBL] [Abstract][Full Text] [Related]
6. HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study.
Sharma K; Shetty DC; Rathore AS; Juneja SA; Katyal S; Krishnatre A
Indian J Pathol Microbiol; 2022; 65(4):761-765. PubMed ID: 36308177
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of tenascin expression in different grades of oral submucous fibrosis.
Tak J; Rao NN; Chandra A; Gupta N
J Oral Maxillofac Pathol; 2015; 19(3):291-6. PubMed ID: 26980955
[TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen degradation products in betel nut chewers - with and without oral submucous fibrosis.
Kiran G; Muni Sekhar M; Hunasgi S; Ahmed SA; Suri C; Krishna A
J Oral Maxillofac Pathol; 2013 Sep; 17(3):324-8. PubMed ID: 24574646
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis.
Suwasini S; Shrikaar M; Kumari N; Singh A; Kumari K; Kumar M
J Int Soc Prev Community Dent; 2021; 11(4):448-456. PubMed ID: 34430507
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis.
Mahapatra N; Dash KC; Bhuyan L; Panda A; Behura SS; Mishra P
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S264-S267. PubMed ID: 33149468
[TBL] [Abstract][Full Text] [Related]
11. Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis.
Sarode G; Sarode SC; Deshmukh R; Raktade P; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):443-447. PubMed ID: 28029690
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
13. Qualitative Analysis of Collagen Fibers in Oral Submucous Fibrosis using Picrosirius Red Stain and Polarising Microscope.
Radhika T; Sekaran P; Narasimhan M
J Clin Diagn Res; 2016 Feb; 10(2):ZC04-7. PubMed ID: 27042575
[TBL] [Abstract][Full Text] [Related]
14. Linking inflammation and angiogenesis with fibrogenesis: Expression of FXIIIA, MMP-9, and VEGF in oral submucous fibrosis.
Choudhari S; Kulkarni D; Patankar S; Kheur S; Sarode S
Rev Esp Patol; 2024; 57(1):15-26. PubMed ID: 38246706
[TBL] [Abstract][Full Text] [Related]
15. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
[TBL] [Abstract][Full Text] [Related]
16. Aggrandizing oral submucous fibrosis grading using an adjunct special stain: A pilot study.
Reshma V; Varsha BK; Rakesh P; Radhika MB; Soumya M; D'Mello S
J Oral Maxillofac Pathol; 2016; 20(1):36-46. PubMed ID: 27194860
[TBL] [Abstract][Full Text] [Related]
17. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
18. Oral Submucous Fibrosis: Correlation of Clinical Grading to Various Habit Factors.
Jha VK; Kandula S; Ningappa Chinnannavar S; Rout P; Mishra S; Bajoria AA
J Int Soc Prev Community Dent; 2019; 9(4):363-371. PubMed ID: 31516870
[TBL] [Abstract][Full Text] [Related]
19. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
20. Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation.
Karnam S; Girish HC; Nayak VN
J Oral Maxillofac Pathol; 2022; 26(2):199-207. PubMed ID: 35968184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
